CYTUNE Trademark

Trademark Overview


On Thursday, December 17, 2020, a trademark application was filed for CYTUNE with the United States Patent and Trademark Office. The USPTO has given the CYTUNE trademark a serial number of 90389015. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by Cytune Pharma S.A.S.. The CYTUNE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer preparations; antitumor drugs in the nature of tumor suppressing agents; vaccines; anticancer vaccines; pharmaceutical preparations for the treatment of neoplasia, tumors, cancer and infectious diseases, namely, peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; radiopharmaceutical preparations for the treatment of neoplasia, tumors and cancer for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious ...

Medical services; medical diagnostic services

Scientific and technological services, namely, research and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases and infectious diseases; pharmaceutical drug development services; conducting clinical trials for others; scientific preclinical and clinical research in the field of prevention and treatment of neoplasia, tumors, cancer and infectious diseases; scientific preclinical and clinical research in the fields of biologics and chemotherapy; analysis of toxicology and mode of action of biological and chemicals and combinations on animals; pharmaceutical and biological product research, development, safety testing, and quality control testing services fo...
cytune

General Information


Serial Number90389015
Word MarkCYTUNE
Filing DateThursday, December 17, 2020
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6849176
Registration DateTuesday, September 20, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "CYTUNE" in black; to the left is an arrowhead shaped figure in oblong lines with the top in magenta and the bottom in orange.
Goods and ServicesPharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer preparations; antitumor drugs in the nature of tumor suppressing agents; vaccines; anticancer vaccines; pharmaceutical preparations for the treatment of neoplasia, tumors, cancer and infectious diseases, namely, peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; radiopharmaceutical preparations for the treatment of neoplasia, tumors and cancer for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; diagnostic agents, preparations and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; drug delivery agents; adjuvants for medical use; dietetic substances adapted for medical use
Indication of Colors claimedThe color(s) black, magenta, and orange is/are claimed as a feature of the mark.
Goods and ServicesMedical services; medical diagnostic services
Goods and ServicesScientific and technological services, namely, research and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases and infectious diseases; pharmaceutical drug development services; conducting clinical trials for others; scientific preclinical and clinical research in the field of prevention and treatment of neoplasia, tumors, cancer and infectious diseases; scientific preclinical and clinical research in the fields of biologics and chemotherapy; analysis of toxicology and mode of action of biological and chemicals and combinations on animals; pharmaceutical and biological product research, development, safety testing, and quality control testing services for others; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services in the nature of computer diagnostic services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 26, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCytune Pharma S.A.S.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNantes F-44100
FR

Party NameCytune Pharma S.A.S.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNantes F-44100
FR

Party NameCytune Pharma S.A.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNantes F-44100
FR

Trademark Events


Event DateEvent Description
Monday, December 21, 2020NEW APPLICATION ENTERED
Friday, February 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 27, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 11, 2021ASSIGNED TO EXAMINER
Tuesday, November 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 18, 2021NON-FINAL ACTION WRITTEN
Friday, June 18, 2021NON-FINAL ACTION E-MAILED
Friday, June 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 29, 2021ASSIGNED TO EXAMINER
Wednesday, December 15, 2021ASSIGNED TO LIE
Saturday, December 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, December 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 27, 2021EXAMINERS AMENDMENT E-MAILED
Monday, December 27, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 27, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, December 28, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 27, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 31, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, February 7, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 11, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, February 7, 2022NON-FINAL ACTION E-MAILED
Monday, February 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER